TY - JOUR
AB - News events associated with the use of lisino- Consumer medication leaflets inadequate, pril or metformin. But just 3% of the leaflets distributed with lisinopril and FDA says 18% of those provided with metformin DA officials say leaflets intended to study conducted in 2001 but far below instructed patients to stop using the F provide consumers with meaning- the congressionally mandated goal. medication immediately after a serious ful information about the prescription “In order to meet this goal, we need to adverse event. medications they receive from pharma- take a different approach,” Seligman said. More than 90% of the leaflets provided cies are largely ineffective, raising the He said the agency plans to work with instructions about taking the medica- possibility that the agency may move stakeholders to develop a “science-based, tions with relation to meals, in adherence to regulate this type of consumer drug evidence-based approach . . . that will al- with criteria on how to use, monitor, and information. low us to ensure that patients are getting benefit from the drugs. But about 70% of “The current system in which the the same high-quality information at any the leaflets told patients that they needed private sector provides 
TI - Appointment and Promotion
JF - American Journal of Health-System Pharmacy
DO - 10.1093/ajhp/66.3.208
DA - 2009-02-01
UR - https://www.deepdyve.com/lp/oxford-university-press/appointment-and-promotion-N6y0D9CMbW
SP - 208
EP - 208
VL - 66
IS - 3
DP - DeepDyve
ER -